The pattern of expression of the voltage-gated sodium channels Nav1.8 and Nav1.9 does not change in uninjured primary sensory neurons in experimental neuropathic pain models

被引:103
|
作者
Decosterd, I [1 ]
Ji, RR
Abdi, S
Tate, S
Woolf, CJ
机构
[1] CHU Vaudois, Dept Anesthesiol, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Div Surg Res, CH-1011 Lausanne, Switzerland
[3] CHU Vaudois, Gene Therapy Ctr, CH-1011 Lausanne, Switzerland
[4] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA
[5] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
[6] GlaxoSmithKline, Discovery Res, Dept Gene Express & Prot Biochem, Stevenage SG1 2NY, Herts, England
关键词
voltage-gated sodium channel; Na(v)1.8; Na(v)1.9; pain; neuropathic pain; nerve injury; dorsal root ganglia;
D O I
10.1016/S0304-3959(01)00456-0
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A spared nerve injury of the sciatic nerve (SNI) or a segmental lesion of the L5 and L6 spinal nerves (SNL) lead to behavioral signs of neuropathic pain in the territory innervated by adjacent uninjured nerve fibers, while a chronic constriction injury (CCI) results in pain sensitivity in the affected area. While alterations in voltage-gated sodium channels (VGSCs) have been shown to contribute to the generation of ectopic activity in the injured neurons, little is known about changes in VGSCs in the neighboring intact dorsal root ganglion (DRG) neurons, even though these cells begin to fire spontaneously. We have now investigated changes in the expression of the TTX-resistant VGSCs, Na(v)1.8 (SNS/PN3) and Na(v)1.9 (SNS2/NaN) by immunohistochemistry in rat models of neuropathic pain both with an intermingling of intact and degenerated axons in the nerve stump (SNL and CCI) and with a co-mingling in the same DRG of neurons with injured and uninjured axons (sciatic axotomy and SNI). The expression of Na(v)1.8 and Na(v)1.9 protein was abolished in all injured DRG neurons, in all models. In intact DRGs and in neighboring non-injured neurons, the expression and the distribution among the A- and C-fiber neuronal populations of Na(v)1.8 and Na(v)1.9 was, however, unchanged. While it is unlikely, therefore, that a change in the expression of TTX-resistant VGSCs in non-injured neurons contributes to neuropathic pain, it is essential that molecular alterations in both injured and non-injured neurons in neuropathic pain models are investigated. (C) 2002 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 45 条
  • [21] Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models
    Urru, Matteo
    Muzzi, Mirko
    Coppi, Elisabetta
    Ranieri, Giuseppe
    Buonvicino, Daniela
    Camaioni, Emidio
    Coppini, Raffaele
    Pugliese, Anna Maria
    Tanaka, Brian
    Estacion, Mark
    Waxman, Stephen G.
    Dib-Hajj, Sulayman
    Chiarugi, Alberto
    PAIN, 2020, 161 (04) : 831 - 841
  • [22] Expression of the sodium channel transcripts Nav1.8 and Nav1.9 in injured dorsal root ganglion neurons of interferon-γ or interferon-γ receptor deficient mice
    Eriksson, J
    Fried, K
    NEUROSCIENCE LETTERS, 2003, 338 (03) : 242 - 246
  • [23] Naja atra venom peptide reduces pain by selectively blocking the voltage-gated sodium channel Nav1.8
    Zhang, Fan
    Zhang, Changxin
    Xu, Xunxun
    Zhang, Yunxiao
    Gong, Xue
    Yang, Zuqin
    Zhang, Heng
    Tang, Dongfang
    Liang, Songping
    Liu, Zhonghua
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (18) : 7324 - 7334
  • [24] Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes
    Horishita, Takafumi
    Yanagihara, Nobuyuki
    Ueno, Susumu
    Okura, Dan
    Horishita, Reiko
    Minami, Tomoko
    Ogata, Yuichi
    Sudo, Yuka
    Uezono, Yasuhito
    Sata, Takeyoshi
    Kawasaki, Takashi
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (12) : 1255 - 1270
  • [25] Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes
    Takafumi Horishita
    Nobuyuki Yanagihara
    Susumu Ueno
    Dan Okura
    Reiko Horishita
    Tomoko Minami
    Yuichi Ogata
    Yuka Sudo
    Yasuhito Uezono
    Takeyoshi Sata
    Takashi Kawasaki
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 1255 - 1270
  • [26] ELECTROPHYSIOLOGICAL ANALYSES OF MUTANTS OF THE HUMAN VOLTAGE-GATED SODIUM CHANNEL NAv1.9 THAT CAUSE PAIN DISORDERS BY ESTABLISHING A HETEROLOGOUS EXPRESSION SYSTEM
    Zhou, Xi
    Xiao, Zhen
    Xu, Yan
    Zhang, Yunxiao
    Tang, Dongfang
    Wu, Xinzhou
    Tang, Cheng
    Chen, Minzhi
    Shi, Xiaoliu
    Liang, Songping
    Liu, Zhonghua
    TOXICON, 2019, 158 : S57 - S57
  • [27] Carvacrol inhibits the neuronal voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.3, Nav1.7, and Nav1.8 expressed in Xenopus oocytes with different potencies
    Horishita, Takafumi
    Ogata, Yuichi
    Horishita, Reiko
    Fukui, Ryo
    Moriwaki, Kuniaki
    Ueno, Susumu
    Yanagihara, Nobuyuki
    Uezono, Yasuhito
    Sudo, Yuka
    Minami, Kouichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2020, 142 (04) : 140 - 147
  • [28] Identification of the sensory neuron specific regulatory region for the mouse gene encoding the voltage-gated sodium channel NaV1.8
    Puhl, Henry L., III
    Ikeda, Stephen R.
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 (03) : 1209 - 1224
  • [29] Changes of voltage-gated sodium channels in sensory nerve regeneration and neuropathic pain models
    Casals-Diaz, Laura
    Casas, Caty
    Navarro, Xavier
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2015, 33 (03) : 321 - 334
  • [30] Histamine Upregulates Nav1.8 Expression in Primary Afferent Neurons via H2 Receptors: Involvement in Neuropathic Pain
    Yue, Jia-Xing
    Wang, Ran-Ran
    Yu, Jie
    Tang, Ying-Ying
    Hou, Wei-Wei
    Lou, Guo-Dong
    Zhang, Shi-Hong
    Chen, Zhong
    CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (10) : 883 - 892